Laurie Toich, Assistant Editor

Drug-drug and drug-food interactions are evaluated in 58 oral chemotherapeutics.

The United States reduced cancer mortality by 26% overall, falling short of the 50% reduction goal set by the American Cancer Society.

Sorafenib for advanced hepatocellular carcinoma may not offer the significantly lengthened life expectancy reported in clinical trials.

Sorafenib for advanced hepatocellular carcinoma may not offer the significantly lengthened life expectancy reported in clinical trials.

Top news of the day from across the healthcare landscape.

Opdivo approved for patients with relapsed or refractory classical Hodgkin lymphoma.

Opdivo approved for patients with relapsed or refractory classical Hodgkin lymphoma.

NASP outlines issues with the new proposed rule for Medicare Part B.

Financial literacy improves financial behaviors, which decreases the likelihood of cost-related nonadherence.

Anti-top1 cancer drugs can potentially stop inflammatory responses that lead to sepsis.

Little clinical guidance exists on how soon after a fracture occurs that osteoporosis medications should be prescribed.

Statin use found to make no difference in colorectal cancer risk, but cholesterol levels could.

Researchers found a protective effect against cancer in patients with autism spectrum disorder.

Top news of the day from across the healthcare landscape.

Lenvatinib with everolimus found to improve progression-free survival in RCC patients.

Increasing costs predicted to increase which drugs are covered by pharmacy benefit managers and payers.

Lenvatinib with everolimus previously granted Breakthrough Therapy Designation and Priority Review.

Levels of TJP1 could potentially determine an effective treatment for patients with multiple myeloma.

Biomarker can help determine the most effective treatment for patients with multiple myeloma.

HDM SLIT with ICS could reduce the risk of moderate or severe asthma exacerbations.

Top news of the day from across the healthcare landscape.

Blocking estrogen production by using an aromatase inhibitor stopped seizures in animal models.

Antiandrogen therapy plus radiotherapy shows promise reducing prostate cancer mortality.

Patients who receive antiandrogen therapy plus radiotherapy decrease their risk of death to 17%.

A high intake of fruit and vegetables in adolescence is linked to a reduced risk of breast cancer, but high alcohol consumption could increase the risk.

Aerosolized SERCA2a gene shown to stop pulmonary hypertension in swine.

Hsp90 inhibitors could improve aggressive, resistant prostate cancer treatment.

FDA says Thalitone was not withdrawn from the market due to safety or efficacy and can potentially have ANDA approvals.

A repository of biopsy tissue was created from patients with leukemia and lymphoma.

Anti-VEGF treatments and better artificial lenses could prevent secondary cataract surgery.